000 01552 a2200433 4500
005 20250516172755.0
264 0 _c20140926
008 201409s 0 0 eng d
022 _a2325-6621
024 7 _a10.1513/AnnalsATS.201305-136OC
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMarras, Theodore K
245 0 0 _aOpinions differ by expertise in Mycobacterium avium complex disease.
_h[electronic resource]
260 _bAnnals of the American Thoracic Society
_cJan 2014
300 _a17-22 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Intramural
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aCanada
650 0 4 _aClinical Competence
650 0 4 _aConsensus
650 0 4 _aDelayed Diagnosis
650 0 4 _aHumans
650 0 4 _aInfectious Disease Medicine
_xstandards
650 0 4 _aMedical Staff
_xstandards
650 0 4 _aMycobacterium avium-intracellulare Infection
_xdiagnosis
650 0 4 _aPractice Guidelines as Topic
650 0 4 _aPrognosis
650 0 4 _aPulmonary Medicine
_xstandards
650 0 4 _aRecurrence
650 0 4 _aRemission, Spontaneous
650 0 4 _aSurvival Rate
650 0 4 _aTuberculosis, Pulmonary
_xdiagnosis
650 0 4 _aUnited States
700 1 _aPrevots, D Rebecca
700 1 _aJamieson, Frances B
700 1 _aWinthrop, Kevin L
773 0 _tAnnals of the American Thoracic Society
_gvol. 11
_gno. 1
_gp. 17-22
856 4 0 _uhttps://doi.org/10.1513/AnnalsATS.201305-136OC
_zAvailable from publisher's website
999 _c23132846
_d23132846